Author:
Melnyk Charlena Janice,Wagner Karen Dineen
Abstract
Parents and patients have inquired about the safety and efficacy of cannabidiol (CBD) in treating child and adolescent mental health conditions. This review examines the current literature regarding CBD containing less than 0.3% tetrahydrocannabinol (THC) in treatment of childhood psychiatric disorders for youth 20 years and younger. Although there are several areas of growing interest for potential use of CBD, such as social anxiety disorder and autism spectrum disorder, the evidence base remains limited. Large-scale controlled trials are needed to determine the efficacy of CBD for treatment of child and adolescent psychiatric disorders.
[
Psychiatr Ann
. 2024;54(6):e186–e192.]
Reference53 articles.
1. Cannabidiol (CBD) Oil, Cancer, and Symptom Management: A Google Trends Analysis of Public Interest
2. Clark S. CBD and Parents' Attitudes About Giving it to Children. University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health. Published February 21, 2022. https://ihpi.umich.edu/news/cbd-and-parents-attitudes-about-giving-it-children
3. Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
4. Measurement of social-evaluative anxiety.
5. Social Phobia